Valerio Therapeutics is teaming up with Abivax to discover new treatments for immune-mediated inflammatory diseases. The deal will provide funding to help advance Valerio’s internal pipeline, including a cell therapy candidate for IgG4‑related disease (IgG4‑RD), an immune-mediated inflammatory disease. “This collaboration brings together two highly complementary scientific…
Discussion
Although I’ve probably had immunoglobulin G4-related disease (IgG4-RD) for over 30 years, I was officially diagnosed about 10 years ago. Despite this, until recently, I’d never told anyone about it apart from medical professionals. I’d always be vague about what was ailing me, brushing it off when anyone asked.
Discussion
A Phase 2 clinical trial Spero Therapeutics plans to start next year will test an investigational antibody-based therapy in people with immunoglobulin G4-related disease (IgG4-RD). Spero recently signed an exclusive license agreement with Innovent Biologics, the treatment’s original developer, that grants the company worldwide exclusive rights to develop, produce, and…
Get regular updates to your inbox.
